Trilogy Capital’s Invesco S&P Spin-Off ETF CSD Stock Holding History

Trilogy Capital’s Portfolio CSD Stock Details CSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-27	Closed	-$1K	–	218
2018 Q3	$1K	Hold	27	–	–	﹤0.01%	544
2018 Q2	$1K	Hold	27	–	–	﹤0.01%	506
2018 Q1	$1K	Buy	+27	New	+$1.46K	﹤0.01%	432

Other funds holding CSD

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

NCMW

Northern Capital Management (Wisconsin) Madison, Wisconsin $373M AUM 11.01% 1-Year Est. Return

WMG

WESCAP Management Group Glendale, California $508M AUM 18.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Trilogy Capital's CSD Position: Q4 2018 in Review

Trilogy Capital sold out of Invesco S&P Spin-Off ETF (CSD) in Q4 2018, closing a stake of 27 shares — an estimated $1K sold.

Trilogy Capital first reported a position in CSD in Q1 2018 and held it in 3 quarters. The position peaked at $1K in Q3 2018. 45 funds tracked by Wall St. Rank hold CSD as of Q4 2018.

Trilogy Capital reported no remaining Invesco S&P Spin-Off ETF position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 27 Invesco S&P Spin-Off ETF shares in Q4 2018, an estimated $1K.
Trilogy Capital first reported a position in Invesco S&P Spin-Off ETF in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Invesco S&P Spin-Off ETF position peaked at $1K in Q3 2018.
45 funds tracked by Wall St. Rank held Invesco S&P Spin-Off ETF as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.